TLDR Older women taking spironolactone for hair loss may need yearly potassium checks due to a higher risk of hyperkalemia.
A retrospective case series examined the incidence of hyperkalemia in 53 women aged 66 and older, with an average age of 71, who were taking spironolactone for female pattern hair loss (FPHL). The study found that nearly 10% of these patients developed hyperkalemia, defined as serum potassium >5.0 mEq/L, within the first year of use. Notably, the affected patients had no history of renal disease or hypertension. These findings suggest an increased risk of hyperkalemia in older women using spironolactone for FPHL, indicating that routine yearly potassium monitoring may be necessary for this demographic.
September 2022 in “Journal of The American Academy of Dermatology” Older women taking spironolactone for hair loss may need yearly potassium checks due to a higher risk of hyperkalemia.
1 citations
,
November 2020 in “Journal of The American Academy of Dermatology” GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.
1 citations
,
September 2020 in “Actas Dermo-Sifiliográficas” 
30 citations
,
March 2011 in “Australasian Journal of Dermatology” Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.
26 citations
,
April 2009 in “Australasian Journal of Dermatology” Spironolactone successfully treated hair loss in a 9-year-old girl.
21 citations
,
January 2007 in “Australasian Journal of Dermatology” Spironolactone and minoxidil together effectively treat female pattern hair loss.
16 citations
,
January 1987 in “Dermatology” The spironolactone cream did not reduce hair growth in women with hirsutism.
9 citations
,
April 1986 in “Postgraduate Medicine” Hair loss has many causes and treatments, and losing some hair daily is normal; proper diagnosis is key, and minoxidil can help treat it.
